Safe-BioPharma Association
2005
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Developer of digital identity and signature standard designed to provide global, enhanced assurance identity trust for cyber-transactions. The company's digital identity and signature standard offers a secure, enforceable and regulatory-compliant way to verify digital identities and to apply digital signatures in electronic transactions, eliminates paper works and improves business processes, enabling biopharmaceutical industries to mitigates legal, regulatory and other business risk associated with electronic transactions.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Security Services (B2B)
Other Industries
Application Software
Parent Company
National Health Information Sharing and Analysis Center
Primary Office
- 82 North Summit Street
- Suite 2
- Tenafly, NJ 07670
- United States
+1 (903) 000-0000
Safe-BioPharma Association Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Safe-BioPharma Association‘s full profile, request access.
Request full access to PitchBookSafe-BioPharma Association Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Peter Alterman Ph.D | Chief Operating Officer, Operations & Chief Policy Officer | ||
| Gary Secrest | Chief Technology Officer, Technology & Board Member |
1 Former Executive
You’re viewing 2 of 3 executives. Get the full list »Safe-BioPharma Association Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000 0000000 | Safe-BioPharma Association | Chief Technology Officer, Technology & Board Member | 000 0000 |